The EyeFlowCell: Development of a 3D-Printed Dissolution Test Setup for Intravitreal Dosage Forms
An in vitro dissolution model, the so-called EyeFlowCell (EFC), was developed to test intravitreal dosage forms, simulating parameters such as the gel-like consistency of the vitreous body. The developed model consists of a stereolithography 3D-printed flow-through cell with a polyacrylamide (PAA) g...
Main Authors: | Tobias Auel, Linus Großmann, Lukas Schulig, Werner Weitschies, Anne Seidlitz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/9/1394 |
Similar Items
-
Safety of intravitreal triamcinolone acetonide:an electrophysiologic and histopathological study in rabbits
by: Laila Hassan M. El-Shazly, et al.
Published: (2013-12-01) -
The influence of intravitreally applied triamcinolone acetonide on vitreal hemorrhage resorption and visual acuity in patients with proliferative diabetic retinopathy
by: Petrović Nenad, et al.
Published: (2018-01-01) -
Non-steroidal anti-inflammatory drug in adjuvant treatment of intravitreal triamcinolone acetonide for macular edema
by: Xiao-Juan Liu, et al.
Published: (2016-06-01) -
Intravitreal injection of conbercept combined with triamcinolone acetonide for diabetic macular edema
by: Jun Li<sup>*</sup>, et al.
Published: (2019-03-01) -
Modified low-dose triamcinolone acetonide intravitreal injection for macular cystoid edema after cataract surgery
by: Hai-Xiao Feng, et al.
Published: (2019-11-01)